VIAL HEALTH TECHNOLOGY, INC.

Client	Reported $	Filings	Share
VIAL HEALTH TECHNOLOGY, INC.	$280.0K	2	100.0%

Issue	Activities	Share
`HCR` Health Issues	2	100.0%

Entity	Contacts	Share	Type
Defense, Dept of (DOD)	2	11.1%	Agency
Executive Office of the President (EOP)	2	11.1%	Agency
Food & Drug Administration (FDA)	2	11.1%	Agency
HOUSE OF REPRESENTATIVES	2	11.1%	Congress
Health & Human Services, Dept of (HHS)	2	11.1%	Agency
Natl Institutes of Health (NIH)	2	11.1%	Agency
SENATE	2	11.1%	Congress
Vice President of the U.S.	2	11.1%	Agency
White House Office	2	11.1%	Agency

0 of 1 lobbyist (0%) listed a prior covered government position on a lobbying filing.

1 report on file for 2025 (latest version of each); 1 reported no contributions.

Posted	Period	Client	Type	Income	Expenses	Activities	Lobbyists
2026-03-31	2026 Q1	VIAL HEALTH TECHNOLOGY, INC.	`1st Quarter - Termination`	—	—	1	1
2026-01-26	2025 Q4	VIAL HEALTH TECHNOLOGY, INC.	`4th Quarter - Report`	—	$280.0K	1	1
2025-10-20	2025 Q3	VIAL HEALTH TECHNOLOGY, INC.	`3rd Quarter - Report`	—	$280.0K	1	1
2025-07-09	2025 Q3	VIAL HEALTH TECHNOLOGY, INC.	`Registration`	—	—	1	1

PAOLO MASTRANGELO

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.

Income & Lobbyist Activity Last 10 years, by quarter

Clients from the last four reported quarters (1) · ranked by reported income and expenses

Issues lobbied last four reported quarters

Government entities contacted last four reported quarters

Revolving door lobbyists active in the last 12 months

Political contributions semiannual LD-203 reports by the firm and its lobbyists

Filings 4 total

Lobbyists active in the last 12 months (1)